Jennifer Mathieu, senior vice president of professional and government affairs at AMCP, provides an update on the Access to Prescription Digital Therapeutics Act 2023 moving through Congress.
Operator: Good day and thank you for standing by, and welcome to the Better Therapeutics Second Quarter 2023 Update Call. At this time all participants are in a listen-only mode.
Megan Coder, chief policy officer and founding member of the Digital Therapeutics Alliance, discusses a recent bill that could affect the nascent sector.